alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › equal

equal

2 studies tagged equal, dated 2014-05-06 to 2023-10-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Digital phenotyping: An equal opportunity approach to reducing disparities in Alzheimer's disease and related dementia research 2023-10-01
  2. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway 2014-05-06

Studies

2 studies carry this tag.

Date range

2014 to 2023

Top journals

  • Alzheimer's & dementia (Amsterdam, Netherlands) 1
  • The FEBS journal 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Digital phenotyping: An equal opportunity approach to reducing disparities in Alzheimer's disease and related dementia research

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Alzheimer's & dementia (Amsterdam, Netherlands) 2023-10-01 Cognitive tests and assessment

    A rapidly aging world population is fueling a concomitant increase in Alzheimer's disease (AD) and related dementias (ADRD).

  2. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. The FEBS journal 2014-05-06 Biomarkers

    Fibrillar amyloid-β (Aβ) is the major constituent of senile plaques in the brain of patients with Alzheimer's disease (AD).

All topic tags with their study counts